Learn more about a clinical trial examining a potential new treatment for depression in adult patients. Managing symptoms of depression can feel overwhelming, but you are not alone. If you experience ...
Australian R&D company MindBio Therapeutics conducted a first-ever Phase 2a take-home microdosing trial to treat depression.. 53% of patients went into complete depression remission after 8 weeks of ...
Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the ...
STAMFORD, Conn.--(BUSINESS WIRE)--Purdue Pharma L.P. (“Purdue”) today announced The Journal of Clinical Pharmacology has published findings from a study in healthy adult volunteers that demonstrated ...
Prof. Dr. Guido van Wingen discusses the potential of, and barriers to, the use of AI in transforming the treatment of depression ...
StudyFinds on MSN
AI chatbots may be worsening mental illnesses for many patients, new clinical data suggests
In A Nutshell Researchers searching over 10.7 million psychiatric patient records in Denmark found 38 cases where AI chatbot use appeared compatible with potential mental health harm, spanning ...
Consuming large amounts of ultraprocessed foods may be linked to depression, research published Wednesday found. Ultraprocessed foods are high in salt, sugar, hydrogenated fats and additives. They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results